ASD vs FTXH
Defiance Autism Impact ETF against First Trust Nasdaq Pharmaceuticals ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
17%
9 shared positions
Fee gap
19 bp
FTXH is cheaper
1-year return gap
—
Larger fund
FTXH
$1.1B
Side by side
| ASD | FTXH | |
|---|---|---|
| Fund | Defiance Autism Impact ETF | First Trust Nasdaq Pharmaceuticals ETF |
| Issuer | Defiance | First Trust |
| Category | ESG & Values | Health Care |
| Expense ratio | 0.79% | 0.60% |
| Assets | $1.4M | $1.1B |
| Average daily dollar volume | $7K | $10M |
| Listed | Jun 1, 2026 | Sep 20, 2016 |
| FrenzyCap score | 16 | 51 |
| 1-month return | −1.2% | +1.8% |
| 3-month return | −1.4% | +7.9% |
| Year to date | — | +25.3% |
| 1-year return | — | +40.7% |
| 30-day volatility | 12.1% | 15.2% |
| Worst drawdown, 1 year | −7.7% | −7.5% |
| Trailing 12-month yield | 0.03% | 0.70% |
| Holdings | 39 | 51 |
| Top 10 weight | 30.8% | 53.1% |
| Look-through P/E | — | 43.5 |
| Holdings vs fair value | +17.6% | +7.5% |
| Holdings above 200-day average | 55% | 83% |
| Net flow, latest 3 reported months | +$1.3M thru Jun 2026 | +$3.3M thru Jun 2026 |
| 30-day implied volatility | — | 37.9% |
| Holdings as of | as of Jun 30, 2026SEC filing | as of Jun 30, 2026SEC filing |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
23% of ASD · 36% of FTXH
Sector mix of the stock holdings
| Sector | ASD | FTXH | Gap |
|---|---|---|---|
| Health Care | 46.8% | 92.7% | −45.9% |
| Consumer Discretionary | 6.8% | 0.0% | +6.8% |
| Technology | 2.7% | 2.8% | −0.1% |
| Other | 2.7% | 0.0% | +2.7% |
More: full overlap table · ASD holdings · FTXH holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.